India  

Authorities to bear hospitalisation cost post Covaxin jab: Health Ministry

Video Credit: ANI - Duration: 01:30s - Published
Authorities to bear hospitalisation cost post Covaxin jab: Health Ministry

Authorities to bear hospitalisation cost post Covaxin jab: Health Ministry

Health and Family Welfare Ministry of India on January 19 said that in case of the Covaxin which has been given emergency use authorization under clinical trial mode (Covaxin), hospitalization cost would be borne by authorities.

He said, "There are two vaccines.

One of the two vaccines is given emergency use authorization under clinical trial mode.

In a document for this vaccine, it's mentioned that if there's causal relation between immunization and adverse event weather it is severe or serious, hospitalization cost would be borne by authorities."


You Might Like


💡 newsR Knowledge: Other News Mentions

BBV152 BBV152 Vaccine against COVID-19

Covaxin has 81% interim vaccine efficacy - here's what it means

The trials for the third phase of the vaccine involved 25,800 subjects and it was the largest ever conducted in India.
DNA

Covaxin shows 81% efficacy, say ICMR and Bharat Biotech

This interim efficacy trend puts Covaxin at par with other global front-runner vaccines, the desi vaccine’s co-developer, the Indian Council for Medical..
IndiaTimes
Uddhav Thackeray: We Don’t Have To Learn Hindutva From You | Oneindia News [Video]

Uddhav Thackeray: We Don’t Have To Learn Hindutva From You | Oneindia News

Arvind Kejriwal slams BJP saying the party has failed to govern the municipal corporations in Delhi. Karnataka Minister resigns on moral grounds after tape scandal. Maharashtra Chief Minister Uddhav Thackeray slams BJP and RSS. In a statement made by Bharat Biotech, the biotechnology company claims that the Covaxin is 81 percent effective in preventing Covid and can work against the UK variant of the virus. TMC meets Election Commission over PM's photo on vaccine documents #PMModi #ArvindKejriwal #KarnatakaMinisterSexTape

Credit: Oneindia    Duration: 02:43Published
'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech [Video]

'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech

Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial. "Today is an important day for us, country and Indian science. COVAXIN has demonstrated an interim vaccine efficacy of around 80.6% in its Phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR," Bharat Biotech chairman Dr Krishna Ella.

Credit: ANI    Duration: 01:42Published

Covaxin demonstrates 81% efficacy, says Bharat Biotech on Phase 3 results

Covaxin is one of two Covid vaccines that was granted emergency use approval in the country in early January.
DNA

Related videos from verified sources

Only 0.0004% of vaccinated people hospitalised so far: Govt [Video]

Only 0.0004% of vaccinated people hospitalised so far: Govt

Union Health Ministry on February 12 informed that 33 people have been hospitalised post vaccination so far, of which 21 have been discharged, and 10 have died. "Percentage of hospitalisation as..

Credit: ANI     Duration: 01:14Published
No case of hospitalisation post vaccination in past 24 hours: Govt [Video]

No case of hospitalisation post vaccination in past 24 hours: Govt

Additional Secretary of Union Health Ministry, Manohar Agnani informed that COVID hospitalisations till date are 28. Out of these, 19 have been discharged after treatment and there have been 9 deaths...

Credit: ANI     Duration: 02:14Published
‘22 deaths reported so far post Covid-19 vaccination’: Health Ministry [Video]

‘22 deaths reported so far post Covid-19 vaccination’: Health Ministry

Union health ministry addressed a briefing on Covid-19 vaccination. Ministry's Additional Secretary Manohar Agnani said, "As of February 5, a total of 52,90,474 beneficiaries have been vaccinated. A..

Credit: HT Digital Content     Duration: 02:19Published